000 | 01928 a2200589 4500 | ||
---|---|---|---|
005 | 20250517014302.0 | ||
264 | 0 | _c20160628 | |
008 | 201606s 0 0 eng d | ||
022 | _a1468-3288 | ||
024 | 7 |
_a10.1136/gutjnl-2014-308735 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGrimm, Wesley A | |
245 | 0 | 0 |
_aThe Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. _h[electronic resource] |
260 |
_bGut _cMar 2016 |
||
300 |
_a456-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenocarcinoma _xgenetics |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAutophagy-Related Proteins |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aColorectal Neoplasms _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon Type I _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 | _aSurvival Analysis |
700 | 1 | _aMesser, Jeannette S | |
700 | 1 | _aMurphy, Stephen F | |
700 | 1 | _aNero, Thomas | |
700 | 1 | _aLodolce, James P | |
700 | 1 | _aWeber, Christopher R | |
700 | 1 | _aLogsdon, Mark F | |
700 | 1 | _aBartulis, Sarah | |
700 | 1 | _aSylvester, Brooke E | |
700 | 1 | _aSpringer, Amanda | |
700 | 1 | _aDougherty, Urszula | |
700 | 1 | _aNiewold, Timothy B | |
700 | 1 | _aKupfer, Sonia S | |
700 | 1 | _aEllis, Nathan | |
700 | 1 | _aHuo, Dezheng | |
700 | 1 | _aBissonnette, Marc | |
700 | 1 | _aBoone, David L | |
773 | 0 |
_tGut _gvol. 65 _gno. 3 _gp. 456-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/gutjnl-2014-308735 _zAvailable from publisher's website |
999 |
_c24588762 _d24588762 |